INVO Bioscience, Inc. Quarterly Return On Assets in % from Q4 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
INVO Bioscience, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2012 to Q2 2024.
  • INVO Bioscience, Inc. Return On Assets for the quarter ending June 30, 2024 was -36.9 %, a 80.3% increase year-over-year.
  • INVO Bioscience, Inc. annual Return On Assets for 2023 was -60.5 %, a 67.1% increase from 2022.
  • INVO Bioscience, Inc. annual Return On Assets for 2022 was -184 %, a 167% decline from 2021.
  • INVO Bioscience, Inc. annual Return On Assets for 2021 was -68.7 %, a 67.3% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -36.9 +150 +80.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -43.4 +156 +78.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.5 +123 +67.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -96.9 +13 +11.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -187 -92.5 -97.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -200 -125 -165% Jan 1, 2023 Mar 31, 2023
Q4 2022 -184 -115 -167% Oct 1, 2022 Dec 31, 2022
Q3 2022 -110 -4.61 -4.38% Jul 1, 2022 Sep 30, 2022
Q2 2022 -94.9 +25.4 +21.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -75.3 +73.6 +49.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -68.7 +141 +67.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -105 +209 +66.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -120 +102 +45.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -149 -4.16 -2.87% Jan 1, 2021 Mar 31, 2021
Q4 2020 -210 -133 -173% Oct 1, 2020 Dec 31, 2020
Q3 2020 -314 -229 -268% Jul 1, 2020 Sep 30, 2020
Q2 2020 -222 -140 -170% Apr 1, 2020 Jun 30, 2020
Q1 2020 -145 +69 +32.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -77 +314 +80.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -85.2 +295 +77.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -82.2 +410 +83.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -214 +50.6 +19.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -391 -57.7 -17.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -380 -19.9 -5.53% Jul 1, 2018 Sep 30, 2018
Q2 2018 -492 -173 -54.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -264 +387 +59.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -333 +173 +34.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -360 +63.8 +15% Jul 1, 2017 Sep 30, 2017
Q2 2017 -319 +131 +29% Apr 1, 2017 Jun 30, 2017
Q1 2017 -651 +687 +51.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -506 +1.37K +73% Oct 1, 2016 Dec 31, 2016
Q3 2016 -424 +3.69K +89.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -450 +4.48K +90.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -1.34K +302 +18.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -1.88K -265 -16.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -4.11K -3.61K -716% Jul 1, 2015 Sep 30, 2015
Q2 2015 -4.93K -4.36K -760% Apr 1, 2015 Jun 30, 2015
Q1 2015 -1.64K -1.15K -233% Jan 1, 2015 Mar 31, 2015
Q4 2014 -1.61K -962 -148% Oct 1, 2014 Dec 31, 2014
Q3 2014 -505 +58.7 +10.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -574 -18.1 -3.25% Apr 1, 2014 Jun 30, 2014
Q1 2014 -492 +52.7 +9.67% Jan 1, 2014 Mar 31, 2014
Q4 2013 -648 -158 -32.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -563 Jul 1, 2013 Sep 30, 2013
Q2 2013 -556 Apr 1, 2013 Jun 30, 2013
Q1 2013 -545 Jan 1, 2013 Mar 31, 2013
Q4 2012 -490 Oct 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.